Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03841435 · ClinicalTrials.gov registry record · NA
Hypofractionated Radiotherapy for Recurrent DIPG
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03841435: Completed NA study, sponsored by University of Cincinnati.
NCT03841435 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03841435, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study evaluates the feasibility of hypofractionated radiotherapy (RT) in the palliative treatment of recurrent diffuse intrinsic pontine glioma (DIPG). Participants will receive 15 Gy in 3 fractions as opposed to the standard 20 Gy in 10 fractions.
Primary Outcome
RTOG common toxicity criteria grade 0-5
Interventions
- RADIATION Hypofractionated Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-01-31 |
| Est. Completion | 2023-03-03 |
| Phase | NA |
What the finished NCT03841435 record still lists
NCT03841435 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Hypofractionated Radiotherapy is the first listed.
NCT03841435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03841435 about?
NCT03841435 is a clinical study titled "Hypofractionated Radiotherapy for Recurrent DIPG". This study evaluates the feasibility of hypofractionated radiotherapy (RT) in the palliative treatment of recurrent diffuse intrinsic pontine glioma (DIPG). Participants will receive 15 Gy in 3 fractions as opposed to the standard 20 Gy in 10 fractions.
What is the current status of trial NCT03841435?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-01-31. Estimated completion is 2023-03-03.
What interventions are being tested in trial NCT03841435?
The interventions under investigation include: Hypofractionated Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT03841435?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03841435's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI